Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...
Picard Medical, parent company of SynCardia, announced the completion of an in vivo study of its Emperor platform.
The company completed an acute in vivo...
Reflow Medical announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable stent system.
San Clemente, California-based Reflow designed its...
EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS).
CAPTURE-2 evaluates the safety and...
Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy.
Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...
Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study.
REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...
CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy.
Barostim delivers electrical pulses to baroreceptors in the...
Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system.
Findings published in the Journal of Neurointerventional...
CorTec GmbH announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled...